Stockscreener 앱 받기
26.26
1.72%
-0.46
전일 마감가:
$26.72
열려 있는:
$26.15
하루 거래량:
8.22M
Relative Volume:
0.78
시가총액:
$10.16B
수익:
$3.14B
순이익/손실:
$-3.36B
주가수익비율:
-3.008
EPS:
-8.73
순현금흐름:
$-4.03B
1주 성능:
+5.63%
1개월 성능:
-1.06%
6개월 성능:
-36.12%
1년 성능:
-83.99%
1일 변동 폭
$25.55
$26.49
1주일 범위
$24.71
$30.30
52주 변동 폭
$23.15
$170.47
모더나 Stock (MRNA) Company Profile
명칭
Moderna Inc
전화
(617) 714-6500
주소
325 BINNEY STREET, CAMBRIDGE
MRNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
26.26 | 9.61B | 3.14B | -3.36B | -4.03B | -8.73 |
|
ONC
Beigene Ltd Adr
|
241.43 | 27.03B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
436.00 | 112.64B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.335 | 40.86M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.34 | 64.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
75.06 | 6.07B | 0 | -153.72M | -103.81M | -2.00 |
모더나 Stock (MRNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | Citigroup | Neutral |
| 2025-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-01-29 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-12-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-19 | 개시 | Berenberg | Hold |
| 2024-11-18 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-09-13 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-09-13 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-09-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-08-28 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2024-08-07 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-08-05 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | 다운그레이드 | HSBC Securities | Hold → Reduce |
| 2024-01-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-11-29 | 개시 | Canaccord Genuity | Hold |
| 2023-11-03 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2023-11-02 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2023-08-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-07-24 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Reduce |
| 2023-06-26 | 업그레이드 | UBS | Neutral → Buy |
| 2023-04-26 | 개시 | Guggenheim | Neutral |
| 2023-03-13 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | 개시 | RBC Capital Mkts | Outperform |
| 2023-02-24 | 다운그레이드 | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-12-14 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | 업그레이드 | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-02-01 | 업그레이드 | Redburn | Sell → Neutral |
| 2022-01-26 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2022-01-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-21 | 개시 | UBS | Neutral |
| 2021-12-07 | 개시 | Cowen | Market Perform |
| 2021-11-09 | 개시 | Wolfe Research | Outperform |
| 2021-10-22 | 개시 | Deutsche Bank | Sell |
| 2021-10-15 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-08-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | 재확인 | Jefferies | Hold |
| 2021-02-01 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-12-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-23 | 개시 | Wells Fargo | Equal Weight |
| 2020-11-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | 개시 | SVB Leerink | Mkt Perform |
| 2020-07-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-07-13 | 개시 | Jefferies | Buy |
| 2020-06-30 | 개시 | Argus | Buy |
| 2020-06-08 | 개시 | Barclays | Overweight |
| 2020-04-30 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | 재개 | BofA/Merrill | Buy |
| 2019-10-25 | 개시 | ROTH Capital | Buy |
| 2019-04-05 | 개시 | Chardan Capital Markets | Buy |
모두보기
모더나 주식(MRNA)의 최신 뉴스
Voloridge Investment Management LLC Increases Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Sells 192,303 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna Files For US FDA Review of Updated COVID-19 Vaccine - marketscreener.com
Moderna’s SWOT analysis: mRNA pioneer’s stock faces pivotal moment - Investing.com
Moderna Inc.: Will Its Oncology Innovations & Pipeline Expansion Become The MUCH NEEDED Breakthrough After The Covid Vaccine? - Smartkarma
JPMorgan Chase & Co. Lowers Moderna (NASDAQ:MRNA) Price Target to $26.00 - MarketBeat
Ameriprise Financial Inc. Purchases 23,007 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Nissay Asset Management Corp Japan ADV Has $1.61 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
300,000 Shares in Moderna, Inc. (NASDAQ:MRNA) Purchased by Tang Capital Management LLC - MarketBeat
Two Sigma Investments LP Has $27.61 Million Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Quantinno Capital Management LP Has $2.97 Million Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review - Insider Monkey
Moderna files application for updated COVID vaccine - WTVB
Moderna, Inc. (NASDAQ:MRNA) Stock Position Boosted by Theleme Partners LLP - MarketBeat
Moderna (MRNA) Seeks FDA Approval for New COVID-19 Vaccine Formu - GuruFocus
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine - USA Today
Moderna Files FDA Application For The Lp.8.1 Targeting Covid-19 Vaccine - marketscreener.com
Moderna files for review of updated COVID vaccine - Reuters
Moderna seeks FDA nod for updated COVID-19 vaccine formula By Investing.com - Investing.com Nigeria
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine | MRNA Stock News - GuruFocus
Moderna seeks FDA nod for updated COVID-19 vaccine formula - Investing.com
Moderna's New COVID Vaccine Takes Aim at Dangerous LP.8.1 VariantFDA Review Begins - Stock Titan
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Nomura Holdings Inc. - MarketBeat
Toronto Dominion Bank Raises Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by ProShare Advisors LLC - MarketBeat
3 ways Moderna is using AI in total rewards - HR Brew
Where Moderna Stands With Analysts - Benzinga
Sender Co & Partners Inc. Acquires New Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna Leads S&P 500 After FDA Eases Booster Concerns - MSN
Changes are happening around COVID-19 vaccines: Here's what to know - The Fayetteville Observer
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines - KMVU FOX 26 Medford
How Moderna Leverages Real-Time Tracking and Thermal Modeling in Its Logistics - Healthcare Packaging
Pharma Logistics: Moderna's Innovative Tracking Solution - Healthcare Packaging
MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot - Yahoo Finance
JP Morgan Lowers Price Target for Moderna (MRNA) to $26 | MRNA Stock News - GuruFocus
FDA Asks Pfizer/BioNTech, Moderna To Add Myocarditis Risk to COVID-19 Vaccines - BioSpace
Moderna Stock Looks Ripe for a Short Squeeze - Investing.com
Moderna Withdraws Application for Combination COVID-19–Influenza Vaccine - NTD News
RNA Therapeutics Industry: Innovation at the Genetic Frontier - PharmiWeb.com
Moderna Stock Looks Ripe for a Short Squeeze - MarketBeat
Analyst recommendations: Target, Fastenal, Moderna, Snowflake, Ulta Beauty… - marketscreener.com
Rafferty Asset Management LLC Reduces Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Why Moderna, Inc. (MRNA) Crashed Today - Yahoo Finance
Moderna, Inc. (MRNA) Withdraws Application for COVID-flu Combination Vaccine - Insider Monkey
10 Firms Drenched in Red Today - Insider Monkey
New Vaccine Framework Avoided Worst-Case Scenario, Analysts Say - insights.citeline.com
Gotham Asset Management LLC Takes $2.67 Million Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna pulls application for flu-COVID combo shot in setback - The Boston Globe
Sector Update: Health Care - marketscreener.com
Brookline keeps Moderna stock Buy rating, $198 target By Investing.com - Investing.com India
Moderna opts to withdraw BLA for mRNA-1083 - The Pharma Letter
모더나 (MRNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
17.27%
1.06%
자본화:
|
볼륨(24시간):